MMJ International Holdings New FDA Multiple Sclerosis Study Pushes Cannabis Components Closer To FDA Approval

MMJ International Holding’s, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research, announced today MMJ’s filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s THC/CBD pharmaceutical compounds for treating and/or preventing symptoms

... read more at: